Please join us for a series of webinars exploring topics in Clinical Psychopharmacology. Our featured speaker is Dr. Judith Steinman, PhD. As past-President of APA Division 55 and Program Director for the nation’s first Postdoctoral Master of Science in Clinical Psychopharmacology, Dr. Steinman will share with you her experience in the field and the importance of prescriptive authority for improved behavioral mental health access.
Monday | Aug 17 | 4:00 PM PT • Ethnic and Cultural Disparities in Pharmacotherapy for Mental Health Disorders
Factors such as ethnicity, gender, age, skin color and have a substantial impact on how patients respond to behavioral therapy and pharmacotherapy. Influences from cultural perceptions to differences in liver enzyme polymorphisms can assist Prescribing Psychologists in determining optimal medication choices or when behavioral therapy may be more suitable than pharmacotherapy. Attendees will gain an understanding of the complex cultural and genetic factors that affect medication response.
Wednesday | Sep 16 | 4:00 PM PT • New Horizons - Clinical Psychopharmacology as a Recognized APA Specialty and Moving Towards Board Certification
On August 8, 2020, the American Society for the Advancement of Pharmacotherapy (ASAP) was recognized as a Specialty by the American Psychological Association (APA) Council of Representatives. This historic accomplishment sets the stage for Clinical Psychopharmacologists who are licensed to prescribe to become board certified. Academic and experiential pathways to becoming a Prescribing Clinical Psychopharmacologist will be discussed.
Monday | Oct 19 | 4:00 PM PT • Neuroscience and Psychopharmacology in the Era of COVID19
The pace at which the health and financial consequences of COVID19 have pervaded society has left us in an overwhelming state of stress. Science and medicine have generated theories that normally are tested over time, but the precipitous climb of mortality and morbidity left us scrambling for answers and hanging our hopes on treatments that ultimately proved ineffective or in some cases hazardous. This presentation will parse out the scientific facts from theory regarding neurological sequelae of COVID19 exposure and how medications prescribed for mental health conditions may interact with treatments used for COVID19.
REGISTER TODAY →
For more information contact Marjorie Boidy • Assoc. Director of Online Admissions email@example.com | 858-635-4749